Clinical evaluation of AB-132 in the management of advanced bronchogenic carcinoma.
D000970:Antineoplastic Agents / Q000628:therapy*; D002277:Carcinoma; D002283:Carcinoma, Bronchogenic / Q000628:therapy*
D000970:Antineoplastic Agents
ANTINEOPLASTIC AGENTS/therapy; CARCINOMA, BRONCHOGENIC/therapy